Rhythm Pharmaceuticals Inc
F:1RV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rhythm Pharmaceuticals Inc
F:1RV
|
US |
|
Protalix Biotherapeutics Inc
F:PBDA
|
US |
|
B
|
Banco de Chile
F:G4RA
|
CL |
|
A
|
Adobe Inc
F:ADB
|
US |
|
S
|
Shanghai Electric Group Co Ltd
XBER:USR
|
CN |
|
M
|
Mosaic Co
BMV:MOS
|
US |
|
C
|
CH Robinson Worldwide Inc
XBER:CH1A
|
US |
|
K
|
KDDI Corp
DUS:DIP
|
JP |
|
C
|
Capital Ltd
SWB:C8D
|
UK |
|
Netscout Systems Inc
NASDAQ:NTCT
|
US |
Wall St Price Targets
1RV Price Targets Summary
Rhythm Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for 1RV is 118.93 EUR with a low forecast of 88.66 EUR and a high forecast of 139.58 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1RV's stock price target?
Price Target
118.93
EUR
According to Wall Street analysts, the average 1-year price target for 1RV is 118.93 EUR with a low forecast of 88.66 EUR and a high forecast of 139.58 EUR.
What is the Revenue forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
41%
The compound annual growth rate for Revenue over the next 8 years is 41%.
What is the Gross Profit forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
51%
The compound annual growth rate for Gross Profit over the next 6 years is 51%.
